Serum exosomal hsa-miR-142–5p, hsa-miR-1908–5p, and hsa-miR-450b–5p as candidate biomarkers for recurrent depressive disorder diagnosis and ECT treatment response: A preliminary investigation
Serum exosomal miRNAs, particularly hsa-miR-142-5p, hsa-miR-1908-5p, and hsa-miR-450b-5p, emerged as promising candidates for further investigation as biomarkers for RDD diagnosis and treatment monitoring. Larger, multi-center studies are warranted to validate these findings.
Authors
- Jin‐Fang Ge (ORCID: https://orcid.org/0000-0002-6289-9934)
- Yanyan Xu (ORCID: https://orcid.org/0000-0002-4890-3685)
- Ke Fang (ORCID: https://orcid.org/0000-0001-7675-6478)
- Meng Liu (ORCID: https://orcid.org/0009-0009-8750-1679)
- Kun Wang (ORCID: https://orcid.org/0000-0001-9851-7080)
- Yuan Wu (ORCID: https://orcid.org/0000-0002-0900-8629)
- Lihong Zhang (ORCID: https://orcid.org/0000-0003-0183-3517)
- Mingliang He (ORCID: https://orcid.org/0000-0001-6157-1171)
- Xiaorui Wang (ORCID: https://orcid.org/0009-0003-6675-5094)
Institutions
- Anhui Medical University (CN)
- Lu'an First People's Hospital (CN)
Publication Details
- Journal
- Brain Research Bulletin
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1016/j.brainresbull.2025.111345
- Citations
- 3
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 2.81